sumi.news
Search
Following
Sign in
← Back to news
Markets
RSS Feed
sumi.news
Markets
Follow
Latest
Sat Nov 29
Plug Power's New CEO Aims to Make the Company Profitable by 2028. How Likely Is That to Happen?
1w
Y
Micron Logs Sales Jump, Sees Further Growth as AI Demand Outpaces Supply
1w
Y
Embattled BP replaces CEO, naming Woodside Energy chief as first-ever woman leader of a Big Oil giant
1w
Y
No small token: Chinese firms convert prized trees, tea into digital assets
1w
Y
Coinbase pushes into stock trading, event contracts as retail battle heats up
1w
Y
Coinbase Unveils Prediction Markets, Stock Trading and Solana DeFi Integration
1w
Y
Coinbase Global Wants to Be More Than a Crypto Exchange—Much More
1w
Y
CFTC's acting chief Pham poised to go to crypto firm MoonPay once Mike Selig lands
1w
Y
ETF Fund Flows as of December 17, 2025
1w
Y
Coinbase Joins With Kalshi to Enter the Surging Prediction-Markets Business
1w
Y
MillerKnoll (MLKN) Q2 2026 Earnings Transcript
1w
Y
Electricity Auction Highlights Soaring Prices, Reliability Worries
1w
Y
Heard on the Street Recap: Another AI Selloff
1w
Y
New Zealand’s Economy Rebounds Strongly In Third Quarter
1w
Y
AI-Themed Stocks Take More Hits, Sending Nasdaq Lower
1w
Y
Micron Gives Upbeat Forecast Amid AI Boom
1w
Y
HSBC Downgrades Biogen Inc. (BIIB) to Reduce Despite Pipeline Progress
1w
Y
Analysts Split on AbbVie Inc. (ABBV) as BofA Cuts Target and HSBC Turns Bullish
1w
Y
UBS Reiterates Neutral on Novo Nordisk A/S (NVO) Despite Wegovy Dose Progress
1w
Y
Truist Sees Upside in Lantheus Holdings, Inc. (LNTH) Despite PYLARIFY Pressure
1w
Y
This REIT Is Down 60% Since 2006, but a $9.2 Million Bet Says There’s Still Value
1w
Y
Merck & Co., Inc. (MRK) Sees Mixed Analyst Views as Europe Advances WINREVAIR Review
1w
Y
BofA Raises Teva Pharmaceuticals Industries Limited (TEVA) Target to $32 as Barclays Initiates Overweight
1w
Y
Student loans will look different in 2026. Here's what's changing.
1w
Y
Sanofi (SNY) Shares Under Pressure After JPMorgan and Guggenheim Downgrades
1w
Y
Guggenheim Sets $62 Target on Bristol-Myers Squibb Company (BMY) After FDA Priority Review
1w
Y
Pfizer Inc (PFE) Rating Steady Amid Neutral Market Outlook and Pipeline Progress
1w
Y
In 2025, Long-Term Investing Outlasted the Skeptics
1w
Y
Coinbase Ventures-Backed Stablecoin Bank Triggers Terra UST-Style Fears
1w
Y
These 2 Healthcare Stocks Just Declared Dividend Raises
1w
Y
Basic Materials Roundup: Market Talk
1w
Y
Activist Irenic Pushing Medical-Device Maker Integer to Pursue Sale
1w
Y
A $4.8 Million Reason to Buy AeroVironment Stock Today
1w
Y
Tech, Media & Telecom Roundup: Market Talk
1w
Y
Energy & Utilities Roundup: Market Talk
1w
Y
How Your Retirement Contributions Stack Up Against Others Your Age—And Why It Matters
1w
Y
Financial Services Roundup: Market Talk
1w
Y
Auto & Transport Roundup: Market Talk
1w
Y
Weyerhaeuser’s Push to Replace Met Coal
1w
Y
The average first-time buyer is 40, the oldest on record. Why that means many Americans start homeownership $150K behind
1w
Y
S&P Upgrades Paraguay’s Credit Rating, Citing Private Investment, Economic Stability
1w
Y
Salesforce and Other AI Stocks That Can Catch Up to the Pack
1w
Y
Stocks Settle Sharply Lower as Tech Stocks Routed
1w
Y
What Could Go Right–and Wrong–for Markets in 2026? Money Pros Weigh In.
1w
Y
Micron Stock Surges As Memory-Chip Maker Smashes Estimates
1w
Y
'I'm Not Selling Any Of My Stuff,' Husband Insists As Family Survives On $36K — Wife Uncovers $209K In Credit Cards And Fears Financial Collapse
1w
Y
Micron Q1 Preview: Record Quarter Predicted By Analyst — 'We Recommend Owning The Stock'
1w
Y
Fund Exits $6.6 Million Bausch + Lomb Stake as Shares Lag by 9% This Past Year
1w
Y
This Analyst Says IonQ Stock Can Gain Over 75% from Here. Should You Buy It Now?
1w
Y
GE Vernova Has More Than Doubled This Year. Why It Was the Worst Stock in the S&P 500 Today.
1w
Y
More →